Hualien Tzu Chi Hospital administers Taiwan's first CAR-T cell therapy

撰文GlobalBio & Investment
日期2023-12-31
EnglishFrenchGermanItalianPortugueseRussianSpanish
Hualien Tzu Chi Hospital administers Taiwan's first CAR-T cell therapy under National Health Insurance
Hualien Tzu Chi Hospital marks a milestone on Jan 2nd by administering Taiwan's first CAR-T cell therapy under National Health Insurance. This innovative treatment, conditionally included in the temporary payment list since November 2023, signifies a breakthrough in cancer treatment.

Learn more: https://lnkd.in/gaWZBx-u

Follow #Globalbio for more insights!#CARTtherapy #Healthcare #celltherapy 花蓮慈濟醫院

GlobalBio & Investment

Go Global and Beyond:
A Premier Biomedical Media in Taiwan
下一篇
Dr. Tse Wen Chang, Taiwan's antibody pioneer, invented Xolair which was the first anti-IgE antibody

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務